PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Subcommittee on Health.
Congressional Research Service
Version 00 · Introduced in House · Feb 16, 2006
Prescription Drug Abuse Elimination Act of 2006 -Amends the Federal Food, Drug, and Cosmetic Act to require Internet pharmacies to meet specified criteria, including: (1) providing individuals who access the pharmacy with certain information; (2) obtaining verification of a valid prescription in some circumstances; and (3) providing contact information of the individual dispensing prescription drugs on the site to each state that licenses or authorizes the person to dispense drugs. Prohibits the sale of a prescription drug, or the ownership or operation of an illegal Internet pharmacy, in violation of the requirements of this Act. Allows district courts to order Internet providers to remove access or links to sites that violate this Act.
Directs the Secretary of Health and Human Services to promulgate chain-of-custody requirements to track prescription drugs from the manufacturer through each importer, distributor, and retailer. Deems a drug misbranded if such requirements are not met.
Amends the Controlled Substances Import and Export Act to restrict the importation of a schedule II, III, or IV drug by a U.S. resident without a valid prescription to once during any 30-day period.
Showing the opening paragraphs of the official summary.
Requires the Secretary, acting through the Commissioner of Food and Drugs, to: (1) convene a working group to study and report on pharmaceutical counterfeiting; and (2) study the best methods to ensure that controlled substances are not diverted for unlawful use.
Requires the Secretary to conduct research and report on issues related to prescription drug abuse.
Requires the Administrator of the Substance Abuse and Mental Health Services Administration to maintain a comprehensive, national database on deaths occurring as a result of substance abuse.
People & committees
Rep. Norwood, Charles W. [R-GA-9] · R–GA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 15, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.4769 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.4769 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.4769 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.4769 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.